Isatuximab Approved First-Line for Transplant-Ineligible MM

The CD38 antibody shows improved progression-free survival when added to standard treatment.
Medscape Medical News

source https://www.medscape.com/viewarticle/isatuximab-approved-first-line-transplant-ineligible-mm-2024a1000h7b?src=rss